Intermittent fasting 16:8: what the randomised trials actually show.

Intermittent fasting, and specifically the 16:8 variant — an eight-hour eating window and a sixteen-hour fast — has become one of the most popular dietary strategies of the last decade. It is simple, requires no calorie counting, and comes packaged with an appealing narrative: by aligning eating with circadian biology, you unlock metabolic benefits that standard dieting cannot match. The question is whether the human trials support that narrative, or whether the benefits are mostly what you would expect from any intervention that makes people eat less.

This piece walks through the landmark trials, what they measured, what they found, and where the marketing has outrun the science.

§ What 16:8 actually means

The 16:8 protocol compresses all daily eating into an eight-hour window, with water, black coffee, and unsweetened tea permitted during the sixteen fasting hours. The most common version skips breakfast, eating from noon to 8 p.m. A less common but metabolically interesting version eats breakfast and lunch, finishing by 3 or 4 p.m. — so-called early time-restricted feeding, or eTRE. The protocols are similar in duration but very different in where the window sits relative to the circadian clock.

The theoretical appeal is grounded in real circadian biology. Insulin sensitivity, gastric emptying, and thermogenesis all follow daily rhythms, peaking in the morning and declining in the evening. Eating a large meal late at night, the theory goes, is metabolically handled less well than the same meal at noon. Time-restricted eating leverages this by simply removing the late window.

"The circadian argument is biologically plausible. The question is whether the human trial data shows benefits beyond simple calorie reduction."

§ The Sutton trial: what started the excitement

The most influential early trial was published by Elizabeth Sutton and colleagues in Cell Metabolism in 2018. Five men with prediabetes followed an early time-restricted feeding schedule (eating between 6:30 a.m. and 3:30 p.m.) for five weeks, then crossed over to a conventional twelve-hour eating window for another five weeks. The result: improved insulin sensitivity, lower blood pressure, reduced oxidative stress, and lower evening appetite. Crucially, the participants were not told to reduce calories. They lost no weight.

The finding was genuinely interesting. It suggested that meal timing itself, independent of weight loss, could improve metabolic health. But the study was small (five participants), had no true caloric-matched control group, and the early eating window was extreme by modern standards. It established biological plausibility, not clinical practice.

§ The JAMA Internal Medicine trial: the mood darkens

In 2022, Deying Liu and colleagues published what is arguably the most important TRE trial to date. They randomised 116 adults with overweight or obesity to either a 16:8 time-restricted eating protocol (noon to 8 p.m.) or a conventional three-meal daily eating schedule, for twelve weeks. Importantly, both groups were given a standard weight-loss counselling intervention. The trial was therefore asking: does adding a feeding window to standard advice produce additional benefit?

The result: no. The TRE group lost roughly 0.94 kg over twelve weeks. The control group lost roughly 0.68 kg. The difference was not statistically significant. Lean mass, fasting glucose, HOMA-IR, and lipid panels were also not significantly different between groups. The trial was larger than most, well-controlled, and published in a high-impact journal. It was not good news for the 'metabolic hack' narrative.

§ The JAMA Network Open trial: similar findings

A 2020 trial by Lowe and colleagues, published in JAMA Network Open, randomised 116 women and men with overweight or obesity to twelve-hour or eight-hour eating windows for twelve weeks. Both groups lost weight — roughly 1–2% of body mass — with no significant difference between them. The eight-hour window did not accelerate loss. Again, the mechanism appeared to be spontaneous calorie reduction from a narrower window, not a unique metabolic effect of fasting itself.

§ Early vs. late eating windows: does timing matter?

Where the data gets more interesting is the comparison between early and late time-restricted eating. A 2019 trial by Hutchison and colleagues, published in Obesity, found that a week of late TRE (1–9 p.m.) produced worse glycaemic responses than an early TRE protocol or a standard schedule. This aligns with the circadian literature: insulin sensitivity is genuinely higher in the morning.

The Sutton trial also used an early window and found metabolic improvements without weight loss. No trial has yet replicated this in a fully controlled, calorie-matched design, but the directional signal is consistent. If you are going to try TRE, eating earlier in the day appears more metabolically favourable than skipping breakfast and eating late.

§ What TRE is actually good for

The honest appraisal is that TRE is a behavioural compliance tool, not a metabolic override. For people who snack continuously from dinner to bedtime, a hard stop at 8 p.m. can remove hundreds of discretionary calories without requiring calorie counting or food-group restriction. For people who do not overeat in the evening, it offers no demonstrated advantage over a standard meal pattern that matches calories.

The American Diabetes Association's 2023 consensus report on meal timing acknowledges that time-restricted eating can reduce total energy intake and may improve glycaemic control in some individuals, but notes that the evidence is not strong enough to recommend it as a standard therapy. The European Association for the Study of Diabetes has issued similar guidance.

§ What the science does not support

Several common claims about intermittent fasting are not supported by the current trial literature.

• →'Fasting puts you into fat-burning mode.' The body burns fat continuously; it simply burns more when total energy intake is lower. The fasting window itself does not uniquely switch on fat oxidation.
• →'TRE boosts metabolism.' Metabolic rate does not increase during short fasts. It may decline slightly, as it does with any calorie reduction.
• →'You can eat whatever you want in the window and still lose weight.' If the window contains excess calories, weight is not lost. Energy balance still governs outcomes.
• →'Autophagy from fasting will reverse ageing in humans.' Autophagy is induced by fasting in animal models and cell culture. Long-term human health effects are entirely unproven.

§ A practical framework

For most adults, the following is consistent with the evidence:

• →If you tend to overeat in the evening, a 16:8 window with an early stop (finish by 6–7 p.m.) is a reasonable behavioural strategy.
• →Do not expect magic. The weight loss, if it occurs, comes from reduced intake, not from the window itself.
• →If you train in the morning, a hard fast until noon may impair performance and recovery. Adjust the window to your life, not the other way around.
• →Avoid late TRE (eating 2–10 p.m.). The circadian evidence suggests it is metabolically worse than a standard schedule.
• →Pregnant women, people with a history of eating disorders, and those on glucose-lowering medication should not attempt unsupervised time-restricted eating.

§ A closing point

Time-restricted eating is not a scam, but it is also not a hack. It is a structural change to eating patterns that, for some people, reduces total intake without requiring detailed food tracking. That is a real benefit. The metabolic narrative — circadian override, autophagy activation, metabolic magic — is not yet supported by the human trial data. Eat in a window if it helps you. Do not eat in a window because you think it bypasses thermodynamics. Physics does not take holidays.